{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:47:45Z","timestamp":1777963665636,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L242053"],"award-info":[{"award-number":["L242053"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","award":["U01 CK000696\\u201302"],"award-info":[{"award-number":["U01 CK000696\\u201302"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jiph.2025.103109","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:16:31Z","timestamp":1765422991000},"page":"103109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of monovalent vaccines in preventing death and severe disease among Omicron-infected and hospitalized patients in China"],"prefix":"10.1016","volume":"19","author":[{"given":"Ming-Jin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Xi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Tao","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-1483","authenticated-orcid":false,"given":"Li-Qun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jiph.2025.103109_bib1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-022-01855-7","article-title":"Modeling transmission of SARS-CoV-2 Omicron in China","volume":"28","author":"Cai","year":"2022","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jiph.2025.103109_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taad049","article-title":"Reproduction number of SARS-CoV-2 Omicron variants, China, December 2022-January 2023","volume":"30","author":"Bai","year":"2023","journal-title":"J Travel Med"},{"issue":"7","key":"10.1016\/j.jiph.2025.103109_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.46234\/ccdcw2023.026","article-title":"Genomic surveillance for SARS-CoV-2 \u2014 China, September 26, 2022 to January 29, 2023","volume":"5","author":"Wang","year":"2023","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.jiph.2025.103109_bib4","unstructured":"Dennis N. China is flying blind as pandemic rages. Scienceinsider. \u3008https:\/\/www.science.org\/content\/article\/china-flying-blind-pandemic-rages\u3009."},{"key":"10.1016\/j.jiph.2025.103109_bib5","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1038\/s41467-023-39638-4","article-title":"Swift and extensive Omicron outbreak in China after sudden exit from \u2018zero-COVID\u2019 policy","volume":"14","author":"Goldberg","year":"2023","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.jiph.2025.103109_bib6","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3201\/eid2910.230585","article-title":"Estimate of COVID-19 deaths, China, December 2022\u2013February 2023","volume":"29","author":"Du","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.103109_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/vaccines11040739","article-title":"COVID-19 vaccination coverage among 42,565 adults amid the spread of Omicron variant in Beijing, China","volume":"11","author":"Qin","year":"2023","journal-title":"Vaccin (Basel)"},{"issue":"8","key":"10.1016\/j.jiph.2025.103109_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac119","article-title":"Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 Omicron infection in people aged 60 years or above: a case-control study","volume":"29","author":"Wan","year":"2022","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.jiph.2025.103109_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54777","article-title":"Estimation of vaccine effectiveness of CoronaVac and BNT162b2 against severe outcomes over time among patients with SARS-CoV-2 Omicron","volume":"6","author":"Wei","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.jiph.2025.103109_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jinf.2023.05.020","article-title":"Effectiveness of mRNA and inactivated COVID-19 vaccines: a test-negative study in an infection-na\u00efve Hong Kong population","volume":"87","author":"Ng","year":"2023","journal-title":"J Infect"},{"issue":"17","key":"10.1016\/j.jiph.2025.103109_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.46234\/ccdcw2023.070","article-title":"Effectiveness of COVID-19 vaccination against SARS-CoV-2 Omicron variant infection and symptoms - China, December 2022-February 2023","volume":"5","author":"Fu","year":"2023","journal-title":"China CDC Wkly"},{"issue":"1","key":"10.1016\/j.jiph.2025.103109_bib12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12931-023-02542-y","article-title":"Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts","volume":"24","author":"Zeng","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.jiph.2025.103109_bib13","unstructured":"The World Health Organization. Evaluation of COVID-19 Vaccine Effectiveness. 2021; \u3008https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1\u3009."},{"issue":"1","key":"10.1016\/j.jiph.2025.103109_bib14","doi-asserted-by":"crossref","DOI":"10.2196\/22794","article-title":"The association between chronic disease and serious COVID-19 outcomes and its influence on risk perception: survey study and database analysis","volume":"7","author":"Laires","year":"2021","journal-title":"JMIR Public Health Surveill"},{"issue":"7","key":"10.1016\/j.jiph.2025.103109_bib15","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/s41591-023-02414-4","article-title":"SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease","volume":"29","author":"Barnes","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jiph.2025.103109_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1195908","article-title":"Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies","volume":"11","author":"Song","year":"2023","journal-title":"Front Public Health"},{"issue":"15","key":"10.1016\/j.jiph.2025.103109_bib17","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.vaccine.2024.04.049","article-title":"A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants","volume":"42","author":"Song","year":"2024","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jiph.2025.103109_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29402","article-title":"Effect of inactivated vaccine boosters against severe and critical COVID-19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China","volume":"96","author":"Gan","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiph.2025.103109_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41591-023-02241-7","article-title":"Determinants of COVID-19 vaccination status and hesitancy among older adults in China","volume":"29","author":"Wang","year":"2023","journal-title":"Nat Med"},{"issue":"37","key":"10.1016\/j.jiph.2025.103109_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.46234\/ccdcw2022.173","article-title":"Promote COVID-19 vaccination for older adults in China","volume":"4","author":"Zang","year":"2022","journal-title":"China CDC Wkly"},{"issue":"1","key":"10.1016\/j.jiph.2025.103109_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61583-5","article-title":"Enhancing vaccination uptake through community engagement: evidence from China","volume":"14","author":"Guan","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jiph.2025.103109_bib22","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"STOP-COVID investigators. Factors associated with death in critically ill patients with Coronavirus disease 2019 in the US","volume":"180","author":"Gupta","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.jiph.2025.103109_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2023.151471","article-title":"COVID and the kidney: an update","volume":"43","author":"Bell","year":"2023","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.1016\/j.jiph.2025.103109_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfad283","article-title":"Risk factors for COVID-19 hospitalization and mortality in patients with chronic kidney disease: a nationwide cohort study","volume":"17","author":"Artborg","year":"2023","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.jiph.2025.103109_bib25","doi-asserted-by":"crossref","first-page":"2103168","DOI":"10.1183\/13993003.03168-2021","article-title":"Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study","volume":"60","author":"Lambourg","year":"2022","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jiph.2025.103109_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10650","article-title":"Evaluation of waning of SARS-CoV-2 vaccine-induced immunity: a systematic review and meta-analysis","volume":"6","author":"Menegale","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.jiph.2025.103109_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jinf.2023.08.005","article-title":"COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study","volume":"87","author":"Whitaker","year":"2023","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.jiph.2025.103109_bib28","article-title":"Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression","volume":"29","author":"Pranata","year":"2020","journal-title":"J Stroke Cereb Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.103109_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chest.2020.04.010","article-title":"Risk factors of fatal outcome in hospitalized subjects with Coronavirus disease 2019 from a nationwide analysis in China","volume":"158","author":"Chen","year":"2020","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.jiph.2025.103109_bib30","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1473-3099(23)00272-4","article-title":"Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on Omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study","volume":"23","author":"Lin","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2025.103109_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad161","article-title":"Hybrid immunity provides protective advantage over vaccination or prior remote Coronavirus Disease 2019 alone","volume":"10","author":"Virk","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.103109_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1473-3099(23)00112-3","article-title":"Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen","volume":"23","author":"Huang","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.103109_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40001-022-00710-2","article-title":"SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis","volume":"27","author":"Azami","year":"2022","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jiph.2025.103109_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/01410768251366880","article-title":"Quantifying the impact of immortal time bias: empirical evidence from meta-analyses","author":"Kim","year":"2025","journal-title":"J R Soc Med"},{"issue":"1","key":"10.1016\/j.jiph.2025.103109_bib35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41392-023-01724-w","article-title":"Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period","volume":"8","author":"Ao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"10.1016\/j.jiph.2025.103109_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/01410768211032850","article-title":"TLC Study Group. Symptoms, complications and management of long COVID: a review","volume":"114","author":"Aiyegbusi","year":"2021","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jiph.2025.103109_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66270-1","article-title":"Covid-19 and cardiovascular disease in a total population-study of long-term effects, social factors and Covid-19-vaccination","volume":"16","author":"Spetz","year":"2025","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.jiph.2025.103109_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.64.14.37","article-title":"Neuro-ophthalmic adverse events of COVID-19 infection and vaccines: a nationwide cohort study","volume":"64","author":"Han","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125004587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:31:40Z","timestamp":1773934300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125004587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1876034125004587"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103109","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of monovalent vaccines in preventing death and severe disease among Omicron-infected and hospitalized patients in China","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103109"}}